Cejemly

Medicinal product

(Invented) name

Cejemly

Active substance (s)

Sugemalimabas

Strength

600 mg

Pharmaceutical form

koncentratas infuziniam tirpalui

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L01FF11, sugemalimab

Marketing authorisation holder

CStone Pharmaceuticals Ireland Limited, Airija

Date of authorisation

2024-07-24

Date of renewal

Documents

Cejemly paciento kortele.pdf

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Flakone (20 ml) tirpalo yra:	20 ml
Sugemalimabas	600 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
114658	100765	1100765	flakonas	N2		Receptinis	EU/1/24/1833/001	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2024-07-24	Registruotas